- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03389464
Computer-based Treatment of Dysfunctional Beliefs in Depressive Inpatients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The aim of the present study is to investigate whether confronting depressive patients with their dysfunctional core beliefs via a computer program results in a reduction of the patients' dysfunctional beliefs. Participants will randomly be assigned to the experimental or control group. In the course of the study, experimental participants will be presented with a virtual agent confronting them with their dysfunctional core beliefs (e.g. "You are worthless"). Experimental participants will be instructed to contradict these virtual agents (e.g. "That's not true, I'm a wonderful person").
A group of inpatients (male/female) suffering from depression will participate in the study. The patients will be recruited at the "Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg am Bezirksklinikum Regensburg".
The study will be divided into five sessions taking place on consecutive days. Furthermore, there will be a follow-up.
Session 1:
In the course of this session participants will be informed about the experimental procedure and sign an informed consent. Exclusion criteria will be assessed via self-report and by consulting the responsible therapist. Participants will be asked to fill in the German version of the Beck Depression Inventory-II and German version of the Dysfunctional Attitude Scale. The experimenter will explain the concept of dysfunctional "core beliefs" to the participants and give examples. Participants will be asked to write down three individual core beliefs (e.g. "I'm worthless") and to rate how much they believe in each of these three core beliefs (on a scale ranging from 0% to 100%). Furthermore, participants will be asked to write down alternative beliefs for each of the three core beliefs and to rate (on a scale ranging from 0% to 100%) how much they believe in these alternative beliefs.
Sessions 2 to 4 (intervention):
During these sessions, the experimental participants will be seated in front of a computer. The experimenter will read aloud the participants' core beliefs with the virtual agent on the computer screen moving his lips accordingly. Thus, participants will get the impression of the agent speaking to them. Participants will be instructed to contradict the agent. There will be 10 trials per core belief (30 trials per session, 90 trials in total). At the end of each session, participants will be asked to rate how much they believe in each of their core beliefs as well as in each of their alternative beliefs. Furthermore, they will be asked to rate (on a scale ranging from 0% to 100%) how hard it was for them to contradict the virtual agent. Control subjects will not undergo sessions 2 to 4.
Session 5:
Participants will fill in the German version of the Beck Depression Inventory-II and the German version of Dysfunctional Attitude Scale and give a conviction rating for each of their three core beliefs and each of their alternative beliefs.
Follow-up (after two weeks):
Participants will fill in the German version of the Beck Depression Inventory-II and the German version of the Dysfunctional Attitude Scale and give a conviction rating for each of their three core beliefs and each of their alternative beliefs.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Youssef Shiban, Prof.
- Phone Number: +4955154700445
- Email: shiban@pfh.de
Study Locations
-
-
-
Regensburg, Germany, 93053
- Recruiting
- medbo Bezirksklinikum Regensburg
-
Contact:
- Rainer Rupprecht, Prof.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
• diagnosis of a depressive disorder
Exclusion Criteria:
- substantial and imminent suicide risk
- current psychotic symptoms
- history of psychotic symptoms
- current manic episode
- current diagnosis of alcohol or drug abuse or dependence
- hearing problems
- poor eyesight
- pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: confrontation group
computer-based confrontation with dysfunctional beliefs
|
Patients will be presented with a virtual agent confronting them with their dysfunctional core beliefs (e.g.
"You are worthless").
Participants will be instructed to contradict these virtual agents (e.g.
"That's not true, I'm a wonderful person").
|
No Intervention: control group
no computer-based confrontation with dysfunctional beliefs
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change in the score on the Dysfunctional Attitude Scale
Time Frame: at baseline, one day after the end of the intervention, at follow-up (2 weeks after the end of the intervention)
|
change in the score (ranging from 40 to 280 with higher scores indicating more dysfunctional attitudes) on the German version of the Dysfunctional Attitude Scale
|
at baseline, one day after the end of the intervention, at follow-up (2 weeks after the end of the intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change in the conviction ratings for the dysfunctional beliefs
Time Frame: at baseline, one day after the end of the intervention, at follow-up (2 weeks after the end of the intervention)
|
Participants will be asked to rate (on a scale ranging from 0% to 100%) how much they belief in their dysfunctional beliefs
|
at baseline, one day after the end of the intervention, at follow-up (2 weeks after the end of the intervention)
|
change in the conviction ratings for the alternative beliefs
Time Frame: at baseline, one day after the end of the intervention, at follow-up (2 weeks after the end of the intervention)
|
Participants will be asked to rate (on a scale ranging from 0% to 100%) how much they belief in their alternative beliefs
|
at baseline, one day after the end of the intervention, at follow-up (2 weeks after the end of the intervention)
|
change in the score on the Beck Depression Inventory-II
Time Frame: at baseline, one day after the end of the intervention, at follow-up (2 weeks after the end of the intervention)
|
change in the score (ranging from 0 to 63 with higher scores indicating more severe depressive symptoms) on the German version of the Beck Depression Inventory-II
|
at baseline, one day after the end of the intervention, at follow-up (2 weeks after the end of the intervention)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change in the conviction ratings for the dysfunctional beliefs (exerimental participants only)
Time Frame: at baseline, on the first day of the intervention, on the second day of the intervention, on the third day of the intervention, one day after the end of the intervention, at follow-up (2 weeks after the end of the intervention)
|
Experimental participants will be asked to rate (on a scale ranging from 0% to 100%) how much they belief in their dysfunctional beliefs
|
at baseline, on the first day of the intervention, on the second day of the intervention, on the third day of the intervention, one day after the end of the intervention, at follow-up (2 weeks after the end of the intervention)
|
change in the conviction ratings for the alternative beliefs (exerimental participants only)
Time Frame: at baseline, on the first day of the intervention, on the second day of the intervention, on the third day of the intervention, one day after the end of the intervention, at follow-up (2 weeks after the end of the intervention)
|
Experimental participants will be asked to rate (on a scale ranging from 0% to 100%) how much they belief in their alternative beliefs
|
at baseline, on the first day of the intervention, on the second day of the intervention, on the third day of the intervention, one day after the end of the intervention, at follow-up (2 weeks after the end of the intervention)
|
change in the difficulty ratings (experimental participants only)
Time Frame: on the first day of the intervention, on the second day of the intervention, on the third day of the intervention
|
Experimental participants will be asked to rate (on a scale ranging from 0% to 100%) how hard it was for them to contradict the virtual agent
|
on the first day of the intervention, on the second day of the intervention, on the third day of the intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Youssef Shiban, Prof., PFH - Private University of Applied Sciences
Publications and helpful links
General Publications
- Beck AT, Steer RA, Brown GK. Beck Depression Inventory - Second Edition. Manual. San Antonio, TX: The Psychological Corporation, 1996.
- Hautzinger M, Keller F, Kühner C. BDI-II - Beck Depressions-Inventar - Manual. Frankfurt: Harcourt Test Services, 2006.
- Hautzinger M, Joormann J, Keller F. DAS - Skala dysfunktionaler Einstellungen - Manual. Göttingen: Hogrefe, 2005.
- Weissman AN, Beck AT. Development and validation of the Dysfunctional Attitude Scale: A preliminary investigation. Paper presented at the annual meeting of the Association for the Advancement of Behavior Therapy, Chicago, 1978.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FACE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Lawson Health Research InstituteTerminated
Clinical Trials on computer-based confrontation with dysfunctional beliefs
-
University of ManitobaCompletedVestibular Neuronitis | Peripheral Vestibular Disorders | Vestibular Syndromes &/or Disorders (Labyrinthine)Canada
-
University of ManitobaCompleted
-
National Eye Institute (NEI)UnknownConvergence Insufficiency | Binocular Vision DisorderUnited States
-
Servicio Canario de SaludCompletedGeneralized Anxiety Disorder | GADSpain
-
SIMmersion, LLCTowson UniversityUnknownGender Affirming Communication SkillsUnited States
-
University Hospital, MontpellierRecruitingStaphylococcus AureusFrance
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI); Genentech, Inc.Active, not recruitingMedulloblastomaUnited States, Canada, Australia, New Zealand
-
Indiana UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedDepression | Heart Diseases | Cardiovascular Diseases | Coronary Artery Disease | Stroke | Depressive Symptoms | Major Depressive Disorder | Dysthymic DisorderUnited States